Mass production of unique medical implants has begun in Tolyatti that do not need to be surgically removed — they dissolve on their own inside the patient's body without the need for a repeat operation. Russia's first serial production of bioresorbable products made from a special magnesium alloy under the MgSorb brand has been launched at the Technopark of Tolyatti State University.
The implants are intended for traumatology and maxillofacial surgery. Production of 60 product sizes, including screws and pins, has been established, TSU reported. By April 2026, the company plans to manufacture the first large batch of 2,000 units for warehouse stock in Russian hospitals, which will reduce surgery waiting times for patients.
The MgSorb alloy is biocompatible with the human body, promotes bone tissue regeneration, and has an antimicrobial effect. This is a fully domestic development created to replace imported counterparts. Clinical trials were successfully conducted at the Academician N.N. Burdenko Main Military Clinical Hospital.
In 2026, the company plans to produce 18,000 implants, with a further increase in output to 30,000 per year. Scientists are also developing MgSorb plate implants for complex hand and foot surgeries.